Skip to main content
OpenTrials
Completed

NCT Number: NCT06019143

GoalNav® Clinic Module - Pilot Trial

This is a pilot study to test the feasibility of GoalNav® Clinic, an Electronic Data Capture platform which is specifically designed to collect data on patient goals, live in a clinical setting.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Geriatric Medicine & Memory Disability Clinic, Cape Breton Regional Hospital

Cape Breton, Nova Scotia, B1M 0A1, Canada

About this study

Goal Attainment Scaling (GAS) is an individualized outcome measure that quantifies the effects of an intervention based on personalized goals.

Ardea Outcomes has developed an electronic data capture system called GoalNav® Clinic that is designed to capture GAS data (individual goals) in addition to other outcome measures that is useful to the doctor such as assessment information, patient demographics, cognitive status, etc..

With the help of a study doctor and/or a member of the research team trained in the process of conducting GAS interviews, patients and/or care partners set goals that are meaningful and relevant to them or their loved one's condition. Goals are then followed up in three months, and ratings are provided by the GAS interviewer and patient and/or care partner.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • a new or returning patient who has been referred and has a pre-scheduled appointment to the study doctor's clinic for a geriatric assessment
  • of any age, with or without a disease diagnosis/memory complaint
  • the patient is accompanied by a family member or friend who is willing to participate
  • the patient and/or their care partner must be able to respond to questions in English
  • the patient and their care partner give informed consent

Exclusion criteria

  • the patient does not have a family member or friend who is willing to participate
  • neither the patient nor their care partner can respond to questions in English
  • either or both the patient and care partner decline to provide informed consent
  • the study doctor deems that the patient and/or care partner is not suitable for the study
  • either the patient or their care partner indicates on the informed consent form that they do not wish to be contacted by email or by telephone

Treatment and study plan

Goal Attainment Scaling (GAS) with a goal inventory

Behavioral

Goal Attainment Scaling (GAS) with a goal inventory (list of common goals) as a behavioral interventional tool

Goal Attainment Scaling (GAS) without inventory

Behavioral

Goal Attainment Scaling (GAS) without a goal inventory (list of common goals) as a behavioral interventional tool

Primary outcomes

  1. Goal Setting Survey

    Time frame: 4 months

    The goal setting survey includes multiple choice, Likert type and open-ended questions with respect to the feasibility and acceptability of Goal Attainment Scaling. The questions focus on the impressions and experiences of patients and care partners (in Arm A and Arm B), and the study doctors when conducting interviews using GoalNav® EDC with and without goal inventory. The percentage of participants agreeing with statements with respect to ease of use, time commitment, etc. will be the unit of measurement. The answers to the open-ended questions will also be qualitatively analyzed.

Secondary outcomes

  1. GAS Interviewer Individual Qualitative Interview

    Time frame: 4 months

    The one-hour qualitative interview with GAS interviewers will include questions such as

    • did GAS interviewers use the goal inventory for participants in Arm B (no goal inventory)?
    • was there a difference between Arm A and Arm B in the goal setting process?
    • was there a difference between Arm A and Arm B in goal quality?
    • did patients and care partners in Arm B find it difficult to identify challenges or goal areas without sufficient prompts?

Sponsors and collaborators

Lead sponsor

Ardea Outcomes

Other

Collaborators

  • National Research Council, Canada

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 31, 2023
Registry last updated
Sep 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.